Trials / Unknown
UnknownNCT03510767
A Study of TQ-B3525 on Tolerance and Pharmacokinetics
A Phase I Study of TQ-B3525 on Tolerance and Pharmacokinetics
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To study the pharmacokinetic characteristics of TQ-B3525 in the human body, recommend a reasonable regimen for subsequent research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TQ-B3525 | TQ-B3525 p.o. qd |
Timeline
- Start date
- 2018-06-20
- Primary completion
- 2022-08-15
- Completion
- 2024-08-01
- First posted
- 2018-04-27
- Last updated
- 2023-04-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03510767. Inclusion in this directory is not an endorsement.